Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BTCY NASDAQ:TMDIF NYSE:VAPO NASDAQ:VERO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBTCYBiotricity$0.44-6.1%$0.44$0.19▼$0.83$10.99M1.1237,344 shs44,734 shsTMDIFTitan Medical$0.36+2.9%$0.31$0.03▼$1.00$41.05M1.2674,785 shs4,336 shsVAPOVapotherm$2.17$2.16$0.70▼$3.44$13.58M-1.11N/A51,531 shsVEROVenus Concept$2.46+0.8%$2.51$2.10▼$14.50$3.50M0.1245,754 shs19,413 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBTCYBiotricity0.00%+14.60%+7.87%-13.49%-23.93%TMDIFTitan Medical+2.86%+10.74%+16.36%+39.51%+813.71%VAPOVapotherm0.00%0.00%0.00%0.00%+2.36%VEROVenus Concept0.00%-2.38%-9.89%+2.07%-64.92%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBTCYBiotricityN/AN/AN/AN/AN/AN/AN/AN/ATMDIFTitan MedicalN/AN/AN/AN/AN/AN/AN/AN/AVAPOVapothermN/AN/AN/AN/AN/AN/AN/AN/AVEROVenus Concept1.4399 of 5 stars0.05.00.00.00.63.30.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBTCYBiotricity 2.00HoldN/AN/ATMDIFTitan Medical 0.00N/AN/AN/AVAPOVapotherm 0.00N/AN/AN/AVEROVenus Concept 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBTCYBiotricity$12.06M0.91N/AN/A($1.30) per share-0.34TMDIFTitan Medical$17.63M2.33$18.00 per share0.02$1.05 per share0.34VAPOVapotherm$68.67M0.20N/AN/A($9.01) per share-0.24VEROVenus Concept$61.00M0.06N/AN/A$4.30 per share0.57Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBTCYBiotricity-$14.09M-$0.67N/A∞N/A-80.42%N/A-188.47%8/18/2025 (Estimated)TMDIFTitan Medical$6.95M$0.05N/A∞N/AN/A-82.31%-51.47%N/AVAPOVapotherm-$58.19M-$8.51N/A∞N/A-76.74%N/A-68.08%N/AVEROVenus Concept-$47M-$76.30N/A∞N/A-81.26%-752.29%-54.52%8/14/2025 (Estimated)Latest VERO, VAPO, TMDIF, and BTCY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025VEROVenus Concept-$14.08-$17.44-$3.36-$17.44$14.59 million$13.64 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBTCYBiotricityN/AN/AN/AN/AN/ATMDIFTitan MedicalN/AN/AN/AN/AN/AVAPOVapothermN/AN/AN/AN/AN/AVEROVenus ConceptN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBTCYBiotricityN/A0.230.10TMDIFTitan MedicalN/A3.733.73VAPOVapothermN/A0.250.09VEROVenus Concept7.911.280.79Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBTCYBiotricity3.89%TMDIFTitan Medical0.03%VAPOVapotherm43.08%VEROVenus Concept87.41%Insider OwnershipCompanyInsider OwnershipBTCYBiotricity10.10%TMDIFTitan Medical0.02%VAPOVapotherm15.80%VEROVenus Concept28.04%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBTCYBiotricity4024.91 million22.08 millionOptionableTMDIFTitan Medical50114.04 million4.56 millionNot OptionableVAPOVapotherm2906.26 million5.27 millionNo DataVEROVenus Concept4101.42 million1.03 millionNot OptionableVERO, VAPO, TMDIF, and BTCY HeadlinesRecent News About These CompaniesVenus Concept to Release Second Quarter of Fiscal Year 2025 Financial Results on August 14, 2025July 16, 2025 | globenewswire.comVenus Concept Inc. to Release Q2 Fiscal 2025 Financial Results on August 14, 2025, with Conference Call DetailsJuly 16, 2025 | quiverquant.comQVERO - Venus Concept Inc Financials - MorningstarJuly 8, 2025 | morningstar.comMVenus Concept Executes Debt-to-Equity Exchange AgreementJuly 1, 2025 | tipranks.comVenus Concept Announces $6.5 Million Debt-to-Equity Exchange TransactionJuly 1, 2025 | globenewswire.comVenus Concept Inc News (VERO) - Investing.comJune 26, 2025 | investing.comVenus Concept Stock Climbs After Stock Offering ClosesJune 9, 2025 | marketwatch.comVenus Concept Inc. Closes Registered Direct Offering and Private Placement Raising Approximately $1.15 MillionJune 9, 2025 | quiverquant.comQVenus Concept Announces Closing of Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesJune 9, 2025 | globenewswire.comVenus Concept To Sell Hair Business To Meta Healthcare In $20M All-Cash DealJune 8, 2025 | nasdaq.comVenus Concept prices $3.45M in direct offering, warrants; shares up over 29%June 7, 2025 | msn.comVenus Concept Stock Is Soaring On Friday - Here's WhyJune 7, 2025 | aol.comAVenus Concept Sells Hair Business to Meta HealthcareJune 6, 2025 | tipranks.comVenus Concept Stock Is Soaring On Friday - Here's WhyJune 6, 2025 | benzinga.comVenus Concept Inc.: Venus Concept Announces Definitive Agreement to Sell Venus Hair Business for $20 MillionJune 6, 2025 | finanznachrichten.deVenus Concept Shares Soar on Sale of Hair BusinessJune 6, 2025 | marketwatch.comVenus Concept Announces Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesJune 6, 2025 | globenewswire.comVenus Concept Inc. Sells Venus Hair Business to Meta Healthcare Group in $20 Million DealJune 6, 2025 | quiverquant.comQVenus Concept to sell Venus Hair business for $20M, stock soars 50%June 6, 2025 | msn.comVenus Concept Announces Definitive Agreement to Sell Venus Hair Business for $20 MillionJune 6, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeVERO, VAPO, TMDIF, and BTCY Company DescriptionsBiotricity NASDAQ:BTCY$0.44 -0.03 (-6.15%) As of 08/8/2025 03:34 PM EasternBiotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.Titan Medical NASDAQ:TMDIF$0.36 +0.01 (+2.86%) As of 08/8/2025Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.Vapotherm NYSE:VAPOVapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor that provides compressed air necessary to run the precision flow systems in areas of the hospital without access to a wall gas source; aerosol aeroneb adaptor to facilitate delivery of aerosolized solutions; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol solutions for patients; and tracheostomy adaptors that simplifies the connection of the High Velocity Therapy systems to a tracheostomy collar used to wean patients off mechanical ventilation. In addition, the company offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Module, which helps clinicians maintain oxygen levels within a target range. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.Venus Concept NASDAQ:VERO$2.46 +0.02 (+0.82%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$2.45 -0.01 (-0.41%) As of 08/8/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/04 - 08/08 Rocket Lab Reports Q2 Results: Is the Bull Thesis Still Intact? Airbnb Beats Earnings, But the Growth Story Is Losing Altitude Dutch Bros Just Flipped the Script With a Massive Earnings Beat Amazon Takes an Equity Stake in IonQ—Any Upside Potential? D-Wave Delivers Growth Shock—Investors Eye Quantum Future Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity? Constellation Energy’s Earnings Beat Signals a New Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
